‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue

Original research
par
Clay, Simon et al

Date de publication

2023

Géographie

Australia

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

The aim of this study was to explore what it is like to receive depot buprenorphine and to understand the motivations behind why people discontinue.

Constatations/points à retenir

Participants cited 4 key reasons why they decided to discontinue depot buprenorphine:1) feeling forced into the program, 2) experiencing negative side-effects, 3) finding the treatment ineffective, and 4) wanting to stop depot buprenorphine/OAT to use opioids again or feeling ‘cured’ and no longer in need of OAT. Participants were ultimately discussing issues related to clinician-patient power relations, agency and bodily autonomy, and the pursuit of well-being.

La conception ou méthodologie de recherche

Open-ended, semi-structured interviews (n=40)

Mots clés

Transitions in care/treatment
Substitution/OAT
About PWUD